Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
2021
Background and Purpose: Clinical trials on stroke prevention in patients with atrial fibrillation have consistently shown clinical benefit from either warfarin or non–vitamin K antagonist oral anti...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
3
References
1
Citations
NaN
KQI